A detailed history of Farrow Financial Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Farrow Financial Inc. holds 14,786 shares of DGX stock, worth $2.03 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares
14,786
Previous 15,275 3.2%
Holding current value
$2.03 Million
Previous $2.09 Billion 9.79%
% of portfolio
1.45%
Previous 1.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$137.09 - $137.09 $67,037 - $67,037
-489 Reduced 3.2%
14,786 $2.3 Billion
Q2 2024

Jul 15, 2024

BUY
$125.91 - $144.34 $17,753 - $20,351
141 Added 0.93%
15,275 $2.09 Billion
Q1 2024

May 02, 2024

BUY
$123.78 - $142.11 $196,933 - $226,097
1,591 Added 11.75%
15,134 $2.01 Billion
Q4 2023

Feb 08, 2024

BUY
$120.62 - $141.12 $1.63 Million - $1.91 Million
13,543 New
13,543 $1.87 Billion

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Farrow Financial Inc. Portfolio

Follow Farrow Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farrow Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Farrow Financial Inc. with notifications on news.